Diagnosis and Management of Duchenne Muscular Dystrophy, Part 1: Diagnosis, and Neuromuscular, Rehabilitation, Endocrine, and Gastrointestinal and Nutritional Management
Lancet Neurology
Birnkrant, D. J., Bushby, K., et al. (2018).
Lancet Neurology, 17(3), 251-267.
This consensus guideline provides recommendations on the diagnosis and management of individuals with Duchenne muscular dystrophy. This guideline was updated from the 2-part document from Bushby et al. (2010).
DMD Care Considerations Working Group
This guideline is part of a three-part series of documents, two of which are related to SLP practice. The other document of particular relevance to the Evidence Maps is included in the Associated Article section below.
"Direct physical, occupational, and speech and language therapy should be provided in outpatient and school settings and continue throughout adulthood, augmented by therapies provided during hospital admissions and at home" (p. 257).
As dysphagia is common and frequently progressive in patients with Duchenne muscular dystrophy, anticipatory screening and assessment should be done on a regular basis. "The speech-language pathologist should be consulted for a comprehensive assessment, including a videofluoroscopic swallowing study" (p. 262).
